Microbiological synthesis of beta endorphin
US4350764A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 10, 1980 |
| Grant date | Sep 21, 1982 |
| Priority date | — |
| Expiry date | Mar 10, 2000 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/849
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
DNA comprising the naturally occurring nucleotide sequence coding for amino acids 44-90 of .beta.-lipotropin and including the entire coding region for .beta.-endorphin with the exception of the C-terminal glutamine was modified, transferred to an expression transfer vector, and expressed as a fusion protein. The fusion protein was further modified in vitro to yield mature .beta.-endorphin. .beta.-endorphin was purified from a bacterial lysate. The structure and biological activity of the resulting product was proven by immunological assay, and by two independent assays designed to demonstrate biological activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.